Advertisement
Screener

Scilex Holding Company (SCLX) ROE

Scilex Holding Company (SCLX) ROE

  • 2026-06-30: ROE 150.67%.
  • 2026-03-31: ROE 157.94%.
  • 2025-12-31: ROE 180.02%.
  • 2025-09-30: ROE 189.00%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30150.67%
2026-03-31157.94%
2025-12-31180.02%
2025-09-30189.00%
2025-06-3032.52%
2025-03-3135.23%
2024-12-3137.79%
2024-09-3041.52%
2024-06-3055.38%
2024-03-3156.88%
2023-12-3166.11%
2023-09-3068.12%
2023-06-30-516.32%
2023-03-31-406.05%
2022-12-31-64.47%
2022-09-30779.43%
2022-06-301082.24%
2022-03-31938.44%
2021-12-3139.50%
2021-09-303.56%

Annual ROE

DateROE
2025-12-31180.02%
2024-12-3137.79%
2023-12-3166.11%
2022-12-31-64.47%
2021-12-3139.50%
2020-12-31-253786.58%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21